Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7322194> ?p ?o }
Showing triples 1 to 56 of
56
with 100 triples per page.
- Q7322194 subject Q8760194.
- Q7322194 subject Q9151286.
- Q7322194 abstract "Rib-X Pharmaceuticals, founded in 2000, is an American privately held biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings. The company is located in New Haven, Connecticut. Rib-X seeks to exploit expertise in the structural biology (particularly ribosomal structure) and molecular modeling to design new antibiotics. With this technology they hope to design drug candidates with increased target affinity that overcome bacterial resistance, broadened antibacterial spectrum, and increased efficacy and safety.".
- Q7322194 foundingYear "2000".
- Q7322194 industry Q507443.
- Q7322194 location Q49145.
- Q7322194 product Q4971815.
- Q7322194 regionServed Q16502.
- Q7322194 type Q1589009.
- Q7322194 wikiPageExternalLink www.rib-x.com.
- Q7322194 wikiPageWikiLink Q132592.
- Q7322194 wikiPageWikiLink Q158205.
- Q7322194 wikiPageWikiLink Q1589009.
- Q7322194 wikiPageWikiLink Q16502.
- Q7322194 wikiPageWikiLink Q174858.
- Q7322194 wikiPageWikiLink Q25419.
- Q7322194 wikiPageWikiLink Q30612.
- Q7322194 wikiPageWikiLink Q31856.
- Q7322194 wikiPageWikiLink Q3241189.
- Q7322194 wikiPageWikiLink Q411377.
- Q7322194 wikiPageWikiLink Q42244.
- Q7322194 wikiPageWikiLink Q425555.
- Q7322194 wikiPageWikiLink Q426549.
- Q7322194 wikiPageWikiLink Q49145.
- Q7322194 wikiPageWikiLink Q4971815.
- Q7322194 wikiPageWikiLink Q507443.
- Q7322194 wikiPageWikiLink Q5253067.
- Q7322194 wikiPageWikiLink Q578726.
- Q7322194 wikiPageWikiLink Q595158.
- Q7322194 wikiPageWikiLink Q632006.
- Q7322194 wikiPageWikiLink Q679692.
- Q7322194 wikiPageWikiLink Q7280139.
- Q7322194 wikiPageWikiLink Q857288.
- Q7322194 wikiPageWikiLink Q8760194.
- Q7322194 wikiPageWikiLink Q908902.
- Q7322194 wikiPageWikiLink Q9151286.
- Q7322194 areaServed "Worldwide".
- Q7322194 foundation "2000".
- Q7322194 homepage www.rib-x.com.
- Q7322194 industry Q507443.
- Q7322194 location Q49145.
- Q7322194 name "Rib-X Pharmaceuticals".
- Q7322194 products Q4971815.
- Q7322194 type Q1589009.
- Q7322194 type Organization.
- Q7322194 type Agent.
- Q7322194 type Company.
- Q7322194 type Organisation.
- Q7322194 type Agent.
- Q7322194 type SocialPerson.
- Q7322194 type Thing.
- Q7322194 type Q43229.
- Q7322194 comment "Rib-X Pharmaceuticals, founded in 2000, is an American privately held biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings. The company is located in New Haven, Connecticut. Rib-X seeks to exploit expertise in the structural biology (particularly ribosomal structure) and molecular modeling to design new antibiotics.".
- Q7322194 label "Rib-X Pharmaceuticals".
- Q7322194 homepage www.rib-x.com.
- Q7322194 name "Rib-X Pharmaceuticals".